Dr. Jasvindar Singh, MD

Dr. Singh practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Singh's NPI, 1811931264, was assigned on June 16, 2006. Dr. Singh holds Missouri license 103741.

Dr. Singh's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Singh also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Singh's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Singh is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Singh to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singh practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Singh's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Singh is licensed in Missouri.

CMS data shows 297 Medicare services from Dr. Singh across 8 procedure codes in 2024, for 124 Medicare patients. Medicare paid $40,363 for them.

CMS counts 124 Medicare patients who saw Dr. Singh in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Singh's median patient age at 73, with 32% women.

In 2024, Dr. Singh wrote 250 Medicare Part D claims for 32 patients. 92% of them were for generic drugs. CMS names the drug for 140 of them, across 8 drugs with 11 or more claims each, at $927 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Singh for performance year 2024, reported as part of a group. Dr. Singh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 41 procedures of coronary angioplasty and stenting by Dr. Singh, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 34 papers to Dr. Singh, published from 2012 to 2024. 2013 was the busiest year, with 4. The most frequent topics are Percutaneous Coronary Intervention, Coronary Artery Disease and Coronary Angiography. Dr. Singh has published most often in J Am Heart Assoc. Dr. Singh's most frequent co-authors are Richard G. Bach, MD, Howard I. Kurz, MD and Alan Zajarias, MD.

Dmand AI links Dr. Singh to 6 clinical trials. 2 are still active or recruiting. Conditions studied include Coronary Artery Disease, Coronary Stenosis and Hypertension. Abbott Medical Devices sponsors the most, 3.

CMS Open Payments shows 1,548 general payments to Dr. Singh from 35 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Philips Electronics North America Corporation paid the most, $354,220.